Aytu BioPharma Financials - Benzinga

Aytu BioPharma Inc

AYTUNASDAQ

Trade with Public

Trade with Public

$2.36

N/A

al cierre: Aug 18, 5:00 PM EST

$2.34

-0.02-0.85%

Premercado: 4:00 AM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Informe de acciones

Aytu BioPharma Financials

Aytu BioPharma (AYTU) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Aytu BioPharma Q3 EPS $(0.53) Misses $(0.51) Estimate, Sales $12.411M Beat $12.053M Estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.51) by 3.92 percent. This is a 352.38 percent decrease over earnings of $0.21 per share from

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

Aytu BioPharma Q2 Earnings Report: What Investors Need to Know

Benzinga Insights

Aytu BioPharma Earnings Review: Q2 Summary

Benzinga Insights

Aytu BioPharma Q2 Earnings Summary & Key Takeaways

Benzinga Insights

Aytu BioPharma Q2 Earnings Assessment

Benzinga Insights

© 2026 Benzinga | All Rights Reserved